These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6212272)

  • 1. The efficacy of a topical preparation containing erythromycin in the treatment of acne.
    Puschmann M; Meyer-Rohn J
    Dermatologica; 1982 May; 164(5):343-9. PubMed ID: 6212272
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
    Gloor M; Lamerz A; Franke-Hoffman M
    Zentralbl Bakteriol A; 1981 Feb; 248(4):502-8. PubMed ID: 6452774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of topical erythromycin and oral tetracycline in acne vulgaris.
    Rapaport M; Puhvel SM; Reisner RM
    Cutis; 1982 Jul; 30(1):122-6, 130, 132-5. PubMed ID: 6214377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical erythromycin for acne vulgaris.
    Hellgren L; Vincent J
    Dermatologica; 1980; 161(6):409-14. PubMed ID: 6452297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acne treatment with topical erythromycin and zinc: effect of Propionibacterium acnes and free fatty acid composition.
    Strauss JS; Stranieri AM
    J Am Acad Dermatol; 1984 Jul; 11(1):86-9. PubMed ID: 6234335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative PCR of Propionibacterium acnes DNA in samples aspirated from sebaceous follicles on the normal skin of subjects with or without acne.
    Miura Y; Ishige I; Soejima N; Suzuki Y; Uchida K; Kawana S; Eishi Y
    J Med Dent Sci; 2010 Mar; 57(1):65-74. PubMed ID: 20437767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharma Clinics. Drug of the month. Benzamycin, an up-date on topical treatment of acne].
    Piérard GE
    Rev Med Liege; 1997 Feb; 52(2):120-2. PubMed ID: 9173479
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propionibacterium acnes colonization in acne and nonacne.
    Leyden JJ; McGinley KJ; Vowels B
    Dermatology; 1998; 196(1):55-8. PubMed ID: 9557227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial effect of slaicylic acid on propionibacteria in the sebaceous infundibulum in the local treatment of acne vulgaris].
    Gloor M; Steinbacher M; Franke M
    Z Hautkr; 1979 Oct; 54(19):856-60. PubMed ID: 160687
    [No Abstract]   [Full Text] [Related]  

  • 12. On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients.
    Gloor M; Franke M
    Arch Dermatol Res; 1978 Jun; 262(1):125-9. PubMed ID: 150822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of topical application of dexamethasone on Propionibacteria in the pilosebaceous duct.
    Gloor M; Funder H; Franke M
    Eur J Clin Pharmacol; 1978 Nov; 14(1):53-6. PubMed ID: 729607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is acne vulgaris a genuine inflammatory disease?
    Zouboulis CC
    Dermatology; 2001; 203(4):277-9. PubMed ID: 11752811
    [No Abstract]   [Full Text] [Related]  

  • 15. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W; Stoughton RB
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
    Whiteside JA; Voss JG
    J Invest Dermatol; 1973 Feb; 60(2):94-7. PubMed ID: 4266325
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical acne treatments in Europe and the issue of antimicrobial resistance.
    Leccia MT; Auffret N; Poli F; Claudel JP; Corvec S; Dreno B
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1485-92. PubMed ID: 25677763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI
    Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris.
    Lesher JL; Chalker DK; Smith JG; Guenther LC; Ellis CN; Voorhees JJ; Shalita AR; Klauda HC
    J Am Acad Dermatol; 1985 Mar; 12(3):526-31. PubMed ID: 3157709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of topical erythromycin on aerobic and anaerobic surface flora.
    Bernstein JE; Shalita AR
    Acta Derm Venereol; 1980; 60(6):537-9. PubMed ID: 6162344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.